Loading institutional data...
Loading institutional data...
Held by 1,004 of 5,944 reporting institutions (99th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $95.05 today, the market must believe free cash flow compounds 11.2%/yr for a decade (off $959M normalized FCF).
The market's 11.2% is more optimistic than its 9-yr track record.
2-stage DCF · 0.24B shares · net debt $1.8B
mean 7.4% · volatility σ 12% · implied rate exceeded in 5/9 yrs
Central path = implied 11.2%/yr growth; shaded band = ±1σ (12%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.20B 100.0% | $6.11B 100.0% | $5.87B 100.0% | $5.38B 100.0% | $5.19B 100.0% | $4.90B 100.0% | $4.36B 100.0% | $4.15B 100.0% | $3.78B 100.0% | $3.49B 100.0% |
| Cost of Revenue | $3.43B 55.3% | $3.32B 54.3% | $3.28B 55.9% | $3.13B 58.1% | $2.93B 56.4% | $2.68B 54.8% | $2.37B 54.5% | $2.31B 55.6% | $2.05B 54.2% | $1.90B 54.5% |
| Cost of Products | — | — | — | — | — | — | — | — | $2.05B 54.2% | $1.90B 54.5% |
| Gross Profit | $2.77B 44.7% | $2.79B 45.7% | $2.59B 44.1% | $2.25B 41.9% | $2.26B 43.6% | $2.21B 45.2% | $1.98B 45.5% | $1.84B 44.4% | $1.73B 45.8% | $1.59B 45.5% |
| Research & Development | $145.6M 2.3% | $139.7M 2.3% | $122.4M 2.1% | $110.0M 2.0% | $105.2M 2.0% | $102.6M 2.1% | $93.6M 2.1% | $89.7M 2.2% | $70.8M 1.9% | $63.2M 1.8% |
| Selling, General & Admin | $988.3M 15.9% | $927.8M 15.2% | $889.8M 15.2% | $706.0M 13.1% | $606.7M 11.7% | $593.3M 12.1% | $628.8M 14.4% | $565.9M 13.6% | $542.7M 14.4% | $439.2M 12.6% |
| Operating Income | $1.08B 17.4% | $807.1M 13.2% | $1.06B 18.0% | $597.8M 11.1% | $1.08B 20.8% | $1.03B 21.0% | $840.2M 19.3% | $791.7M 19.1% | $732.7M 19.4% | $724.2M 20.7% |
| Interest Expense | $95.2M 1.5% | $95.0M 1.6% | $110.9M 1.9% | $89.6M 1.7% | $54.5M 1.1% | $61.0M 1.2% | $73.6M 1.7% | $79.4M 1.9% | $52.6M 1.4% | $27.7M 0.8% |
| Other Income (Expense), net | -$56.9M -0.9% | $8.8M 0.1% | -$800K -0.0% | -$1.0M -0.0% | -$2.3M -0.0% | -$2.1M -0.0% | -$1.1M -0.0% | -$3.9M -0.1% | -$300K -0.0% | -$1.5M -0.0% |
| Pretax Income | $956.9M 15.4% | $756.3M 12.4% | $967.4M 16.5% | $523.3M 9.7% | $1.03B 19.9% | $973.8M 19.9% | $773.7M 17.8% | $719.5M 17.4% | $692.7M 18.3% | $705.9M 20.2% |
| Income Tax Expense | $220.1M 3.5% | $171.0M 2.8% | $211.8M 3.6% | $109.4M 2.0% | $204.2M 3.9% | $187.9M 3.8% | $157.8M 3.6% | $150.9M 3.6% | -$50.7M -1.3% | $246.9M 7.1% |
| Net Income | $736.8M 11.9% | $585.3M 9.6% | $755.6M 12.9% | $413.9M 7.7% | $827.5M 15.9% | $785.9M 16.1% | $615.9M 14.1% | $568.6M 13.7% | $743.4M 19.7% | $459.0M 13.1% |
| Per Share | ||||||||||
| EPS (Basic) | $3.04 | $2.39 | $3.09 | $1.70 | $3.38 | $3.18 | $2.50 | $2.32 | $2.97 | $1.78 |
| EPS (Diluted) | $3.02 | $2.37 | $3.05 | $1.68 | $3.32 | $3.12 | $2.44 | $2.27 | $2.90 | $1.75 |
| Weighted Avg Shares (Basic) | 242.7M | 244.4M | 244.9M | 242.9M | 244.9M | 246.8M | 246.2M | 245.5M | 250.6M | 257.6M |
| Weighted Avg Shares (Diluted) | 244.3M | 246.9M | 247.6M | 246.3M | 249.6M | 252.2M | 252.1M | 250.7M | 256.1M | 262.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 26% of free cash flow, leaving room to grow it and fund buybacks. Last year: $287M dividends + $900M buybacks = $1.2B returned on $1.1B FCF.
9 consecutive years of dividend increases · 6%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Modest payoff on reinvested capital. Current ROIC on all capital: 12%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~4.3% on $2.2B of debt.
Cash of $409M fully covers short-term debt of $0.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-09-17
Nothing notable to watch.
No material risks flagged.
Where each multiple sits in its own 14-yr range · 73th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 21.3× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 55.6 | 54.5 | 54.8 | 56.4 | 58.1 | 55.9 | 54.3 | 55.3 |
| Gross Profit | 44.4 | 45.5 | 45.2 | 43.6 | 41.9 | 44.1 | 45.7 | 44.7 |
| R&D | 2.2 | 2.1 | 2.1 | 2.0 | 2.0 | 2.1 | 2.3 | 2.3 |
| SG&A | 13.6 | 14.4 | 12.1 | 11.7 | 13.1 | 15.2 | 15.2 | 15.9 |
| Operating Income | 19.1 | 19.3 | 21.0 | 20.8 | 11.1 | 18.0 | 13.2 | 17.4 |
| Income Tax | 3.6 | 3.6 | 3.8 | 3.9 | 2.0 | 3.6 | 2.8 | 3.5 |
| Net Income | 13.7 | 14.1 | 16.1 | 15.9 | 7.7 | 12.9 | 9.6 | 11.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CHD: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $852.5B | 39.1× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $396.2B | 49.1× | 30.3× | 1.4× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $378.9B | 29.0× | 24.9× | 7.9× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $346.8B | 22.7× | 16.4× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $296.4B | 26.2× | 17.3× | 7.3× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $183.0B | 22.3× | 14.9× | 1.9× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $116.7B | 16.9× | 13.6× | 5.0× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $80.3B | 32.8× | 18.9× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $72.4B | 19.7× | 10.5× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $70.3B | 33.4× | 19.6× | 3.5× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.5B | — | 16.4× | 5.3× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $42.7B | 20.5× | 14.3× | 2.6× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| ADM | $42.6B | 39.5× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| FMX | $41.0B | — | — | — | — | — | — | — | — | — | 290 |
| JBS | $39.7B | — | — | — | — | — | — | — | — | — | 241 |
| KR | $39.6B | 39.5× | 10.0× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| SYY | $38.6B | 21.2× | 9.7× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| KVUE | $34.2B | 23.5× | 11.7× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| HSY | $34.1B | — | 20.1× | 2.9× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| EL | $33.8B | — | 768.2× | 2.4× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| KMB | $32.6B | 16.2× | 10.3× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $29.3B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $27.5B | 18.2× | 8.1× | 0.6× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| KOF | $23.6B | — | — | — | — | — | — | — | — | — | 249 |
| CHD | $23.1B | 31.5× | 18.8× | 3.7× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.7× | 1,004 |
Peers = companies sharing CHD's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.